MedMen goes from height of $3B valuation to zero as stock draws cease-trade order

Once hailed as the first cannabis unicorn, MedMen’s fortunes have gone up in smoke.

Previous post Tyson Foods drops CVS for upstart pharmacy benefit manager, as industry upheaval over cost concerns spreads
Next post Global bond markets are unwinding the rally from December’s ‘Fed pivot party’